微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 10.08% | -20.82% | 60.25% | 27/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 6.29% | -33.23% | 108.97% | 25/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.01% | -42.56% | 207.12% | 34/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -2.81% | -115.08% | -122.07% | 114/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 12.73% | -19.63% | 35.14% | 11/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 9.42% | -13.34% | 79.77% | 7/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 5.24% | -12.08% | -71.89% | 7/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 18.64% | -23.76% | 17.68% | 9/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 15.84% | -23.07% | 45.72% | 8/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 10.87% | -18.94% | 82.38% | 7/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.96% | -12.61% | -75.62% | 8/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 24.45% | 5.03% | 18.75% | 7/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 20.59% | 7.02% | 53.54% | 4/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 13.41% | 3.55% | 96.63% | 6/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 6.82% | 2.56% | -70.7% | 4/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 23.28% | 6.45% | 21% | 14/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 19.24% | 12.25% | 48.57% | 6/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 12.95% | 18.16% | 94.74% | 10/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 6.65% | 11.58% | -69.59% | 8/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 21.87% | 18.09% | 27.6% | 17/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 17.14% | 11.88% | 56.39% | 11/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 10.96% | 9.16% | 83.89% | 11/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 5.96% | 2.41% | -67.82% | 9/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 18.52% | -0.11% | 20.89% | 21/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 15.32% | 4.15% | 52.59% | 10/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 10.04% | 14.48% | 72.51% | 12/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 5.82% | 2% | -68.61% | 9/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 18.54% | 67.93% | 26.04% | 17/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 14.71% | 2% | 67.73% | 15/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 8.77% | 2% | -20.56% | 20/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 11.04% | 85.55% | 85.55% | 50/160 | 6.33% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 5.95% | 20.69% | 20.69% | 70/160 | 11.35% | 华东医药 | 7.2% | 行业排名> |